Mary Weger - Dec 1, 2022 Form 4 Insider Report for PROKIDNEY CORP. (PROK)

Role
Chief People Officer
Signature
/s/ Todd Girolamo, attorney in fact
Stock symbol
PROK
Transactions as of
Dec 1, 2022
Transactions value $
$0
Form type
4
Date filed
1/6/2023, 03:59 PM
Next filing
Jan 18, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PROK Employee stock option (right to buy) Award $0 +450K $0.00 450K Dec 1, 2022 Class A Ordinary Shares 450K $10.25 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The right to purchase common stock vests over four years as follows: 25% on December 1, 2023 and the remaining 75% in substantially equal monthly installments over a 36 month period beginning on December 1, 2023.